Novo Nordisk A/S (NVON.MX)
Novo Nordisk A/S, engages in the research and development, manufacture, and distribution of pharmaceutical products.
812.01-0.09%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-10.8%
The outlook
Novo Nordisk A/S currently reads as leaning bearish based on below its 50- & 200-day averages, 35% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range35% of the way from its 52-week low to high
Market cap
$3.59T
52-wk high
1,140.00
52-wk low
637.43
50-day avg
816.43
200-day avg
826.90
Trailing P/E
11.1